Table 4 Comparison of the previous reports analyzing the perioperative change of serum CEA levels in patients with pathological stage-I NSCLC
Author | Okada[4] | Matsuguma[11] | Wang[15] | Present study | |
|---|---|---|---|---|---|
Year | 2004 | 2008 | 2010 | 2013 | |
CEA measurement period | Before surgery | Within 1 M | Within 1 M | Within 2 W | Within 1 M |
After surgery | Within 1 M | Within 1–3 M | Within 1–3 M | Within 2 M | |
Cut-off point (ng/mL) | 5.0 | 5.0 | 6.0 | 5.0 | |
Total number | 722 a | 455 | 257 | 263 | |
NN group | (5-ys) | 472 (84.2%) | 323 (85.9%) | 173 (71.1%) | 198 (95.5%) |
HN group | 154 (74.2%) | 112 (56.2%) | 56 (54.6%) | 44 (85.5%) b | |
HH group | 96 (48.6%) | 20 (43.1%) | 28 (36.0%) | 21 (59.3%) | |
Independent prognostic factor | N/A | Age | Age | Tumor diameter | |
Histology | HH group | VPI | |||
VPI | HH group | ||||
HN/HH group | |||||